210 related articles for article (PubMed ID: 24608603)
1. MicroRNAs in gastrointestinal malignancy: a tool in cancer prevention?
Mactier KE; Glaire MA; Basavaraju U; El-Omar EM; Hold GL
Eur J Cancer Prev; 2014 Nov; 23(6):540-9. PubMed ID: 24608603
[TBL] [Abstract][Full Text] [Related]
2. Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers.
Albulescu R; Neagu M; Albulescu L; Tanase C
Expert Rev Mol Diagn; 2011 Jan; 11(1):101-20. PubMed ID: 21171925
[TBL] [Abstract][Full Text] [Related]
3. Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis.
Song B; Ju J
Expert Rev Mol Med; 2010 Oct; 12():e33. PubMed ID: 20942990
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2011 Feb; 11(2):145-55. PubMed ID: 21219233
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs as a new potential therapeutic opportunity in gastrointestinal cancer.
Boni V; Bandres E; Zarate R; Colucci G; Maiello E; Garcia-Foncillas J
Oncology; 2009; 77 Suppl 1():75-89. PubMed ID: 20130435
[TBL] [Abstract][Full Text] [Related]
6. The role of microRNAs in gastrointestinal cancers.
Saito Y; Suzuki H; Hibi T
J Gastroenterol; 2009; 44 Suppl 19():18-22. PubMed ID: 19148788
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics.
Gordanpour A; Nam RK; Sugar L; Seth A
Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):314-9. PubMed ID: 22333688
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in an oral cancer context - from basic biology to clinical utility.
Gorenchtein M; Poh CF; Saini R; Garnis C
J Dent Res; 2012 May; 91(5):440-6. PubMed ID: 22166582
[TBL] [Abstract][Full Text] [Related]
9. [microRNA: new diagnostic and therapeutic tools in liver disease?].
Gougelet A; Colnot S
Med Sci (Paris); 2013 Oct; 29(10):861-7. PubMed ID: 24148124
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of small ribonucleic acids in gastrointestinal tumors.
Shapira I; Sultan K; Mehrotra B; Budman DR
Crit Rev Oncol Hematol; 2010 Dec; 76(3):173-85. PubMed ID: 20144549
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA in gastrointestinal cancer: a step closer to reality.
Link A; Goel A
Adv Clin Chem; 2013; 62():221-68. PubMed ID: 24772669
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in cancer management and their modulation by dietary agents.
Karius T; Schnekenburger M; Dicato M; Diederich M
Biochem Pharmacol; 2012 Jun; 83(12):1591-601. PubMed ID: 22342289
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapies and predictive markers in epithelial malignancies of the gastrointestinal tract.
McIntire M; Redston M
Arch Pathol Lab Med; 2012 May; 136(5):496-503. PubMed ID: 22229849
[TBL] [Abstract][Full Text] [Related]
14. miRNAs as molecular biomarkers of cancer.
Fabbri M
Expert Rev Mol Diagn; 2010 May; 10(4):435-44. PubMed ID: 20465498
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.
Macha MA; Seshacharyulu P; Krishn SR; Pai P; Rachagani S; Jain M; Batra SK
Curr Pharm Des; 2014; 20(33):5287-97. PubMed ID: 24479799
[TBL] [Abstract][Full Text] [Related]
16. miRNAs in tumor radiation response: bystanders or participants?
Gandellini P; Rancati T; Valdagni R; Zaffaroni N
Trends Mol Med; 2014 Sep; 20(9):529-39. PubMed ID: 25153824
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in esophageal cancer (review).
He B; Yin B; Wang B; Xia Z; Chen C; Tang J
Mol Med Rep; 2012 Sep; 6(3):459-65. PubMed ID: 22751839
[TBL] [Abstract][Full Text] [Related]
18. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.
Corsini LR; Bronte G; Terrasi M; Amodeo V; Fanale D; Fiorentino E; Cicero G; Bazan V; Russo A
Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S103-9. PubMed ID: 22443195
[TBL] [Abstract][Full Text] [Related]
19. Implication of miRNA in the diagnosis and treatment of breast cancer.
Castañeda CA; Agullo-Ortuño MT; Fresno Vara JA; Cortes-Funes H; Gomez HL; Ciruelos E
Expert Rev Anticancer Ther; 2011 Aug; 11(8):1265-75. PubMed ID: 21916580
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK
Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
